A 38-year-old woman with suspected central sensitization syndrome (fibromyalgia) reports widespread musculoskeletal pain and allodynia. Her clinical examination is non-focal, and basic laboratory investigations are normal. Which investigation would best confirm the presence of central sensitization and dysfunction of descending pain inhibitory pathways?

Explanation

## Investigation of Choice for Central Sensitization Assessment ### Why Conditioned Pain Modulation (CPM) Testing is Correct **Key Point:** Conditioned pain modulation (CPM) is a psychophysical test that directly assesses the function of descending inhibitory pain pathways (endogenous analgesia system). It measures the reduction in pain perception when a noxious conditioning stimulus is applied elsewhere on the body. **High-Yield:** CPM testing protocol: 1. Baseline pain threshold/tolerance measured (e.g., pressure algometry, thermal stimulation) 2. Simultaneous noxious conditioning stimulus applied (e.g., ice water immersion, pressure pain) 3. Re-measure pain response to the original stimulus 4. Normal CPM = significant reduction in pain perception (≥15% decrease indicates intact inhibition) 5. Impaired CPM = minimal or absent pain reduction (hallmark of central sensitization) **Clinical Pearl:** In fibromyalgia and central sensitization syndromes, CPM is typically **impaired or absent**, indicating dysfunction of: - Rostral ventromedial medulla (RVM) - Periaqueductal gray (PAG) - Descending noradrenergic and serotonergic pathways **Mnemonic:** **CPM = Conditioned Pain Modulation** — **C**ontrol pain with **P**ain, **M**easure inhibition. ### Comparison of Investigations | Investigation | What It Assesses | Utility in Central Sensitization | |---|---|---| | **CPM Testing** | Descending inhibitory pathway function | **Gold standard**—directly detects impaired endogenous analgesia | | **Ultrasound** | Muscle structure and inflammation | Non-specific; normal in fibromyalgia | | **CSF Analysis** | Inflammatory cytokines, substance P | Elevated markers support central sensitization but not diagnostic; invasive | | **fMRI (Brainstem)** | Regional brain activation | Research tool; not practical for routine clinical diagnosis | **Warning:** ~~Elevated CSF substance P or cytokines alone do not diagnose central sensitization~~—they are biomarkers supporting the mechanism but require functional assessment (CPM) for clinical confirmation. [cite:Guyton & Hall Physiology 14e Ch 48; Sluka & Clauw 2016]